Methods | Randomised trial comparing parenteral nutrition to no parenteral nutrition in hospitalized patients with alcoholic hepatitis. Geographical location Atlanta, Georgia. Study published 1988. | |
Participants | Inclusion criteria: >80 gm alcohol intake for at least 2 years, right hepatic lobe enlargement, severe alcoholic hep (bilirubin >5 mg% and either primary hepatic encephalopathy or prothrombin time at least 5 sec > control) or moderate alcoholic hepatitis (albumin < 2.9gm% and one of the three criteria for severe hepatitis), and either biopsy‐proven alcoholic hepatitis or, if no biopsy possible, AST <350 IU/l, AST/ALT >2, and actively consuming alcohol at time of admission. Exclusion criteria: Acute pancreatitis, insulin‐dependent diabetes mellitus, positive test for hepatitis B surface antigen, malignancy, hypotension, congestive heart failure, sepsis, severe chronic obstructive pulmonary disease, recent severe trauma or surgery. 34 patients in the full paper, but 69 in a subsequent abstract (age and sex only available for 22 patients in the original paper (7 men/15 women, mean age 41). | |
Interventions | Intervention group received intravenous formulation (35 gm AA, 5% dextrose, minerals, MVI/liter, 2 liters/day, 0.5 liter 10% lipid solution/day) and oral intake offered to control patients; Controls received oral diet (2400 kcal and 100 gm protein) and 1 can Ensure with each meal, 1 mg folic acid/day, multivitamins. Duration therapy 28 days. | |
Outcomes | Mortality (in abstract with 69 patients), appearance/resolution of ascites or hepatic encephalopathy (only for severe subgroup), bilirubin (only for severe subgroup). | |
Category of study | Parenteral nutrition/Medical. | |
Sample size calculation | Not reported if done. | |
Full paper or abstract only | Full paper. | |
Notes | A couple of the numbers in the abstract describing the 69 patients were inconsistent with the original paper, and the data from the larger group were accepted. Address and location not identified for Dr Simon; letter sent to Dr Galambos (John T Galambos, MD, 95 Collier Road, Suite 4075, Atlanta, Georgia 30309) on September 12, 2011. No response has been received as of March 20, 2012. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Only states "randomised". |
Allocation concealment (selection bias) | Unclear risk | Sealed envelope noted, but not mentioned if opaque and/or serially numbered. |
Blinding (performance bias and detection bias) All outcomes | High risk | Not blinded. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Two dropouts in trial reported in full paper; one from each group in those with moderate alcoholic hepatitis, but not stated which reason for which group. No information regarding subsequent report of 69 patients provided as abstract. |
Selective reporting (reporting bias) | Low risk | Mortality and morbidity outcomes reported. |
Other bias | Unclear risk | Funding source not reported. |
Intent to treat analysis | High risk | Could not be done. |
Baseline imbalance? | Low risk | No differences identified. |
Early stopping? | Unclear risk | No sample size calculation and unknown why stopped. |